Sputum-based molecular biomarkers for the early detection of lung cancer: limitations and promise.
about
Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.Altered phosphatidylcholines expression in sputum for diagnosis of non-small cell lung cancer.Altered miR-223 Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer.Sputum-based DNA methylation biomarkers to guide lung cancer screening decisions.
P2860
Sputum-based molecular biomarkers for the early detection of lung cancer: limitations and promise.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sputum-based molecular biomark ...... ncer: limitations and promise.
@en
Sputum-based molecular biomark ...... ncer: limitations and promise.
@nl
type
label
Sputum-based molecular biomark ...... ncer: limitations and promise.
@en
Sputum-based molecular biomark ...... ncer: limitations and promise.
@nl
prefLabel
Sputum-based molecular biomark ...... ncer: limitations and promise.
@en
Sputum-based molecular biomark ...... ncer: limitations and promise.
@nl
P2093
P2860
P356
P1433
P1476
Sputum-based molecular biomark ...... ncer: limitations and promise.
@en
P2093
Connie E Kim
Kam-Meng Tchou-Wong
William N Rom
P2860
P304
P356
10.3390/CANCERS3032975
P577
2011-07-19T00:00:00Z